Could the decline in share price be partly because people think that the GLP1 agonists will mean less heart failure? What causes the heart to fail anyway - I assumed old age, or being afflicted by cardiomyopathy. This forum is full of far more educated people than I, so I would welcome comments.
Ann: Quarterly Activities/Appendix 4C Cash Flow Report, page-6
-
- There are more pages in this discussion • 1 more message in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add EBR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
97.5¢ |
Change
0.000(0.00%) |
Mkt cap ! $300.4M | |||
| Open | High | Low | Value | Volume |
| 0.0¢ | 0.0¢ | 0.0¢ | $0 | 0 |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 1538 | 97.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 80.0¢ | 5617 | 1 |
View Market Depth
| Last trade - 13.24pm 18/09/2024 (20 minute delay) ? |
| EBR (ASX) Chart |
Day chart unavailable